Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-12

Clinical Trial Update: Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of vinorelbine with metronomic administration plus atezolizumab as second-line treatment for stage IV non-small cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atezolizumab (atezolizumab)
  • Vinorelbine (Vinorelbine)

Snippet

Sponsor: University Hospital, Brest | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED